Works matching IS 00070920 AND DT 2018 AND VI 119 AND IP 2

Results: 18
    1
    2
    3
    4
    5
    6
    7
    8

    Early metabolic response in sequential FDG-PET/CT under cetuximab is a predictive marker for clinical response in first-line metastatic colorectal cancer patients: results of the phase II REMOTUX trial.

    Published in:
    2018
    By:
    • Berger, Anne Katrin;
    • Lücke, Stephan;
    • Abel, Ulrich;
    • Haag, Georg Martin;
    • Grüllich, Carsten;
    • Stange, Annika;
    • Dietrich, Mareike;
    • Apostolidis, Leonidas;
    • Freitag, Angelika;
    • Trierweiler, Claudia;
    • von Gall, Carl;
    • Ose, Jennifer;
    • Giesel, Frederik;
    • Weber, Tim Frederik;
    • Lordick, Florian;
    • Haberkorn, Uwe;
    • Jäger, Dirk
    Publication type:
    journal article
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012.

    Published in:
    2018
    By:
    • Mehra, Ranee;
    • Seiwert, Tanguy Y.;
    • Gupta, Shilpa;
    • Weiss, Jared;
    • Gluck, Iris;
    • Eder, Joseph P.;
    • Burtness, Barbara;
    • Tahara, Makoto;
    • Keam, Bhumsuk;
    • Kang, Hyunseok;
    • Muro, Kei;
    • Geva, Ravit;
    • Chung, Hyun Cheol;
    • Lin, Chia-Chi;
    • Aurora-Garg, Deepti;
    • Ray, Archana;
    • Pathiraja, Kumudu;
    • Cheng, Jonathan;
    • Chow, Laura Q. M.;
    • Haddad, Robert
    Publication type:
    journal article
    18